Beginning its seventh year as an industry event, BioPharm America creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up.
It is a pure partnering event focused on one-to-one meetings driven by the partneringONE® software platform that schedules meetings and provides each participant with a dynamic personalized agenda and regular alerts for further meeting opportunities.
The backdrop for this intensive business development activity is a three-day conference program that features leading executives from across the life science industry. At BioPharm America held in Boston in September 2013, panel discussions included licensing, investment and business development executives from Amgen, AstraZeneca, Bayer HealthCare, Biogen Idec, Genentech, Genzyme, Gilead, Ironwood, Janssen Global Services, Merck, Nycomed, Pfizer, and Shire. The event attracted 900+ delegates from 550 companies who participated in 2950+ scheduled one-to-one meetings.
For information about the BioPharm America 2014 program and registration information, please register your email address for regular updates from EBD Group at firstname.lastname@example.org.
ARM MEMBER DISCOUNT: Use the code “ARM Discount” in the comments field upon registration to qualify for $200 off!
Date: September 22-24, 2014
Boston, MA, USA
Marriott Copley Place
110 Huntington Ave
Boston, MA 02116, USA
Producer: EBD Group, Inc.
EBD Group, Inc.
2032 Corte del Nogal, Suite 120
Carlsbad, CA 92011, USA
T: +1 760 930 0500
F: +1 760 930 0520